ACART

ACART. The Automated Closed-Loop Anesthesia and Respiratory Therapy system represents a significant advancement in critical care medicine and operating room technology. It integrates real-time physiological monitoring with automated drug delivery to maintain patient hemodynamics and ventilation within precise therapeutic ranges. This approach aims to reduce anesthesiologist workload and minimize human error during complex surgical procedures and intensive care unit management.

Overview

The core principle involves continuous analysis of data streams from monitors like the bispectral index, electroencephalogram, and invasive blood pressure lines. A central control algorithm, often based on fuzzy logic or model predictive control, processes this information to adjust the infusion rates of agents such as propofol and remifentanil. Pioneering work in this field has been conducted by researchers at institutions like the University of California, San Francisco and the Ghent University Hospital. The system's development is closely related to progress in pharmacokinetic and pharmacodynamic modeling, which predicts drug concentration and effect.

History

Early concepts for automated anesthesia delivery emerged in the 1970s with systems like the "Boston Anesthesia System." The 1990s saw the development of the first clinically tested closed-loop systems for hypnotic agent control, notably using the bispectral index as a primary feedback signal. Key milestones were achieved through collaborations between biomedical engineers at the Massachusetts Institute of Technology and clinicians at the Brigham and Women's Hospital. The evolution of the technology has been chronicled in journals such as Anesthesiology and the British Journal of Anaesthesia. Subsequent generations incorporated opioid delivery and integrated ventilation control, moving toward total intravenous anesthesia management.

Applications

Primary use is in maintaining general anesthesia during lengthy surgeries such as cardiac surgery, neurosurgery, and major oncologic surgery at centers like the Cleveland Clinic. It is also deployed in intensive care unit settings for prolonged sedation of patients with acute respiratory distress syndrome or traumatic brain injury. Research is exploring its utility in specialized environments including magnetic resonance imaging suites and during field hospital operations. The system interfaces with standard hospital equipment from manufacturers like Dräger, GE Healthcare, and Philips.

Technical specifications

The hardware platform typically consists of a ruggedized computer unit interfaced with certified syringe pumps and standard patient monitors. The software architecture employs safety-interlocked control loops, often programmed in languages like C++ or MATLAB/Simulink. Communication protocols adhere to standards like IEEE 11073 for medical device interoperability. System validation involves rigorous testing against scenarios defined in the ISO 80601-2-61 standard for basic safety of ventilators. Key performance metrics include the median performance error and wobble, as defined in studies published in Anesthesia & Analgesia.

Regulatory and ethical considerations

Regulatory approval pathways involve agencies such as the U.S. Food and Drug Administration and the European Medicines Agency, which classify it as a Class III medical device. A major ethical debate centers on algorithmic bias and the transfer of ultimate responsibility from the anesthesiologist to the machine, a topic discussed by the American Society of Anesthesiologists. Data security and protection against cyberattack are paramount, governed by regulations like the Health Insurance Portability and Accountability Act in the United States. International guidelines from the International Organization for Standardization and the International Electrotechnical Commission provide frameworks for risk management and clinical evaluation.

Category:Medical equipment Category:Anesthesia Category:Medical robotics